Merck & Co., Inc.
Merck & Co., Inc., officials announce the latest developments
Published in Managed Care Business Week, August 21st, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Merck & Co., Inc.
Report 1: Late breaking data presented at the American Diabetes Association (ADA) 67th Annual Scientific Sessions showed that, when used investigationally as initial therapy, JANUVIA(TM) (sitagliptin) in combination with metformin provided significant glycemic improvement and was generally well tolerated over 54 weeks in patients with type 2 diabetes. Additional new data from investigational studies presented also showed that JANUVIA significantly improved blood sugar...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Managed Care Business Week
More Articles from Managed Care Business Week
- Abbott
Abbott Chief Operating Officer Richard A. Gonzalez to Retire - AMERISAFE, Inc.
AMERISAFE Announces 2007 Second Quarter Results - AMN Healthcare Services, Inc.
AMN Healthcare Reports Second Quarter 2007 Results and Updates Annual Guidance - Angel.com
MedApps Implements 'Healthcare Anywhere' Program Using Angel.com IVR Application - Angiology
Global Med Technologies Signs Multi-Million Dollar Deal with Fourth Largest Independent Blood Bank in U.S. - Applied Ergonomics
Data on applied ergonomics detailed by P. Entzel and co-authors - More from this issue of Managed Care Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
